UC research examines molecular impact of psychological loss
Study identifies key region of the brain as a molecular target to lessen the impact of loss
Psychological loss can occur when someone loses a job, loses a sense of control or safety or when a spouse dies. Such loss, which erodes well-being and negatively impacts quality of life, may be a common experience but little is known about the molecular process in the brain that occurs because of loss.
New research from the University of Cincinnati explores those mechanisms through a process known as enrichment removal (ER). The study highlights an area of the brain that plays a key role in psychological loss and identifies new molecular targets that may alleviate its impact.
The study was published in the journal Molecular Psychiatry.
The research was led by Marissa Smail, a graduate student in the Department of Pharmacology and Systems Physiology at the UC College of Medicine. She says she’s always been interested in the mechanics underlying psychiatric disorders, in particular what molecular changes happening in the brain make certain symptoms emerge and how those mechanisms can be used to alleviate debilitating conditions.
“Most research in this field focuses on disorders such as depression and PTSD — very worthy causes but not nearly as common as loss,” Smail says. “We have all lost something and experienced the negative impact of that loss at some point. Using ER to understand the mechanisms driving this extremely common experience is a great question that not only sheds light on how we interact with the world but also has the potential to reveal novel therapeutic targets that may be of widespread benefit.”
The research examined animal models which were provided with an environment that gave them the opportunity to climb and explore and enjoy a communal experience of various toys and shelters for four weeks. The ER subjects were then removed from that environment for an extended period (one month) and researchers used a screen of the brain to look at the impact on the region of the brain with established roles in stress regulation and behavioral adaptation following enrichment removal.
“What appears to happen is that in this key area of brain, the amygdala, the support system becomes overactive,” says James Herman, PhD, associate director of the UC Gardner Neuroscience Institute, and Department Chair and the Flor van Maanen Endowed Chair for Pharmacology and Systems Physiology in the UC College of Medicine and senior author of the study. “Rather than being very [adaptable], and being able to be changed, being able to profit from experience, what ends up happening is the neurons become insulated. As a consequence of that insulation, they’re not able to drive the adaptive behaviors that you would normally see on an everyday basis. It’s not the neurons, it’s the insulators of the neurons that are causing this problem and that’s a very novel finding.”
Herman says, unfortunately, that loss is a major contributor to several mental health related conditions. It’s frequently a trigger for depressive episodes and may contribute to the epidemic of mental health consequences linked to isolation during the COVID-19 pandemic.
Smail says one aspect of the research that she likes is that it is very interdisciplinary and collaborative, and it allowed her to explore a variety of topics and techniques to ultimately identify a novel mechanism that occurs in loss.
“Beginning with an unbiased screen meant that this was a true ‘follow the data’ project,” Smail says. “We did not expect to investigate the brain’s immune cells and supporting structure, respectively, but these endpoints led to several great collaborations and a range of molecular and behavioral experiments to understand their roles.
“The resulting mechanism described in the paper is quite novel and shares several characteristics with loss in humans, leading us to believe it is relevant for understanding this common experience.”
Lead image of the amygdala region of the brain/Kateryna Kon/Getty Images
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC research examines molecular impact of psychological loss
September 21, 2023
Research from the University of Cincinnati looks at the molecular impact of psychological loss
UC cocaine research disrupts traditional theory
November 15, 2023
For more than 50 years, the conventional wisdom in the field of cocaine self-administration research has been that people take cocaine based on the theory of the drug providing positive reinforcement to the user. New research out of UC shows that a pharmacological equation disproves that concept and could spark a major shift in that field of research.
Cincinnati Enquirer: UC College of Medicine launches addiction research center
October 2, 2020
A research center devoted to the science of addiction and determined to make a national impact has launched at the University of Cincinnati College of Medicine.
Pop those ‘BPA-free’ drinking bottles into the dishwasher before using them
April 29, 2021
UC research found that some water bottles labeled BPA-free actually contained traces of the chemical and that multiple cycles through the dishwasher was the most effective at removing BPA.
UC-led research team studies role of metabolism in lysosome function
April 11, 2023
The University of Cincinnati's Atsuo Sasaki, PhD, is leading a multidisciplinary team that received National Institutes of Health funding to learn more about how an enzyme that was previously overlooked helps regulate lysosome and cellular function.
Making pancreatic cancer treatments more effective
February 7, 2023
The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.
NIH grant gives underrepresented students insight into the neurosciences at UC
August 12, 2021
Spend your summer at UC learning how neuroscience reserach is conducted
Using electricity to treat cancer
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
UC joins national study on stroke prevention using wearables
November 7, 2022
The University of Cincinnati is part of a multimillion-dollar grant from the National Heart, Lung, and Blood Institute to study a strategy to prevent stroke in patients with atrial fibrillation. The trial will incorporate the use of an app on Apple Watch to monitor an irregular heartbeat to reduce patients’ reliance on blood-thinning medication.
UC research could change vaccine practices
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).